CVE-2026-34324 json
Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: App Server).
published 2026-04-21 6 mo ago modified 2026-10-26 13 d ago also EUVD-2026-24428
- cvss
- 6.5
- version 3.1, CNA
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 0.2%
- EPSS 0.2% chance of exploitation in 30 days, percentile 10%
- public exploits
- 0
- none known
Summary
Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: App Server). Supported versions that are affected are 7.0.1.0 and 7.0.1.1. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
CISA SSVC
- Exploitation
- none
- Automatable
- yes
- Technical impact
- partial
- Assessed
- 6 mo ago
Exploit prediction
0.20% chance of exploitation in the next 30 days, higher than 10% of all scored CVEs (FIRST EPSS, 2026-11-08).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| CNA | 3.1 | 6.5 | CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N |
Affected products
- Oracle Corporation Oracle Life Sciences InForm
Classification
- Weakness
-
- CWE-284 Improper Access Control
References
-
oracle.com
/security-alerts/cpuapr2026.html
vendor-advisory
Sources
- CVE List CVE-2026-34324
- NVD CVE-2026-34324
Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.
CPEs and fixed versions use Anchore's correction of NVD's data: Added CPE configurations because not yet analyzed by NVD.